Stanley J. Meresman - 10 Feb 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Stanley J Meresman
Issuer symbol
GH
Transactions as of
10 Feb 2022
Net transactions value
-$364,129
Form type
4
Filing time
14 Feb 2022, 15:27:48 UTC
Previous filing
12 Jan 2022
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $29,308 +4,934 +122% $5.94 8,993 10 Feb 2022 Direct
transaction GH COMMON STOCK Sale $364,129 -4,934 -55% $73.80 4,059 10 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Options Exercise $29,308 -4,934 -25% $5.94 14,803 10 Feb 2022 COMMON STOCK 4,934 $5.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.